Last Updated: May 3, 2026

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Neomycin And Polymyxin B Sulfates And Hydrocortisone patents expire, and when can generic versions of Neomycin And Polymyxin B Sulfates And Hydrocortisone launch?

Neomycin And Polymyxin B Sulfates And Hydrocortisone is a drug marketed by Amneal, Bausch And Lomb, Sandoz, Saptalis Pharms, and Sciegen Pharms. and is included in eight NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?

Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

US Patents:	0
Applicants:	5
NDAs:	8

US Patents and Regulatory Information for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	217803-001	Oct 29, 2025	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sandoz	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	062488-001	Nov 6, 1985	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Saptalis Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	065216-001	Oct 31, 2005		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	065219-001	May 1, 2006	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Bausch And Lomb	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	064053-001	Dec 29, 1995	AT	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sandoz	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	062423-001	Aug 25, 1983	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Amneal	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	217735-001	Sep 30, 2025	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.